logo
  

U. S. Steel To Consolidate Flat-Rolled Ops, 2,080 Staff To Be Given WARN Notice

United States Steel Corp. (X) said it would consolidate its North American Flat-Rolled operations and temporarily idle its Granite City Works operations in Granite City, Illinois.

As the primary flat-roll supplier of Lone Star Tubular Operations, the consolidation is part of an on-going adjustment of steelmaking operations throughout North America to match customer demands.

The company routinely adjusts production at its operating facilities to reflect market fluctuations. The consolidation is due to challenging market conditions that reflect the cyclical nature of the industry, the firm said.

Global influences in the market like reduced steel prices, unfair trade, imports and fluctuating oil prices, continue to have an impact on the business. The company will be working closely with its customers through this consolidation, and will continue to operate its steelmaking operations in Alabama, Indiana, Michigan and Pennsylvania.

As part of the consolidation, 2,080 employees at Granite City Works are being issued notices under the Worker Adjustment and Retraining Notification Act. These notices are separate from the notices related to the permanent shutdown of Granite City Works' coke making facility.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT